Balchem Corp (BCPC) financial statements: income statement, balance sheet and cash flow
Balchem Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Balchem Corp reported revenue of $1.0B (+8.8% year on year) and net income of $154.8M (+20.5% year on year).
Income statement
Balchem Corp income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$1.0B
$953.7M
$922.4M
$942.4M
Cost of sales
$666.5M
$617.5M
$620.4M
$661.9M
Gross margin
$370.6M
$336.2M
$302.1M
$280.5M
Selling expenses
$75.4M
$68.9M
$74.4M
$67.4M
Research and development expenses
$18.5M
$16.8M
$15.0M
$12.2M
General and administrative expenses
$67.4M
$67.6M
$53.4M
$55.7M
Total operating expenses
$161.3M
$153.3M
$142.9M
$135.3M
Earnings from operations
$209.3M
$182.9M
$159.2M
$145.2M
Interest expense, net
$10.2M
$16.5M
$22.6M
$10.3M
Other expense (income), net
$77.0K
($72.0K)
($681.0K)
$1.2M
Total other expenses
$10.3M
$16.5M
$21.9M
$11.4M
Earnings before income tax expense
$199.0M
$166.5M
$137.3M
$133.7M
Income tax expense
$44.2M
$38.0M
$28.7M
$28.4M
Net earnings
$154.8M
$128.5M
$108.5M
$105.4M
Net earnings per share - basic (in dollars per share)
$4.80
$3.97
$3.38
$3.29
Diluted net earnings per common share (in dollars per share)
$4.75
$3.93
$3.35
$3.25
Balchem Corp income statement, quarters
Line item
Sep 30, 2026 · Q3
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Net sales
$290.7M
$284.0M
$270.7M
$267.6M
Cost of sales
$184.9M
$180.3M
$169.6M
$172.1M
Gross margin
$105.7M
$103.7M
$101.1M
$95.5M
Selling expenses
$20.7M
$21.1M
$21.1M
$19.1M
Research and development expenses
$5.3M
$4.5M
$5.9M
$4.5M
General and administrative expenses
$17.2M
$18.8M
$18.5M
$17.3M
Total operating expenses
$43.3M
$44.5M
$45.5M
$40.9M
Earnings from operations
$62.4M
$59.2M
$55.6M
$54.6M
Interest expense, net
$1.9M
$1.9M
$2.2M
$2.6M
Other expense (income), net
$459.0K
($498.0K)
$891.0K
($94.0K)
Total other (income) expenses
$2.4M
$1.4M
$3.1M
$2.5M
Earnings before income tax expense
$60.0M
$57.8M
$52.5M
$52.0M
Income tax expense
$13.3M
$13.2M
$12.2M
$11.8M
Net earnings
$46.7M
$44.6M
$40.3M
$40.3M
Net earnings per common share - basic (in dollars per share)
$1.47
$1.40
$1.26
$1.25
Net earnings per common share - diluted (in dollars per share)
$1.46
$1.39
$1.25
$1.24
Balance sheet
Balchem Corp balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$74.6M
$49.5M
$64.4M
$66.6M
Accounts receivable, net of allowance for credit losses of $862 and $909 at December 31, 2025 and 2024, respectively
$143.6M
$119.7M
$125.3M
$131.6M
Inventories, net
$131.4M
$130.8M
$109.5M
$119.7M
Prepaid expenses
$9.8M
$8.1M
$7.8M
$4.9M
Other current assets
$6.2M
$5.7M
$7.2M
$7.1M
Total current assets
$365.6M
$313.8M
$314.2M
$335.8M
Property, plant and equipment, net
$306.6M
$282.2M
$276.0M
$271.4M
Goodwill
$816.4M
$780.0M
$778.9M
$769.5M
Customer relationships and lists
$133.0M
$165.1M
$191.2M
$213.3M
Other intangible assets with finite lives, net
$30.3M
—
—
—
Right of use assets - operating leases
$14.7M
$15.3M
$17.8M
$17.1M
Right of use assets - finance lease
$1.5M
$1.7M
$2.1M
$2.3M
Other non-current assets
$18.1M
$17.3M
$16.9M
$15.1M
Total assets
$1.7B
$1.6B
$1.6B
$1.6B
Trade accounts payable
$60.4M
$54.7M
$55.5M
$57.3M
Accrued expenses
$49.3M
$43.8M
$40.9M
$36.7M
Accrued compensation and other benefits
$27.9M
$22.9M
$17.2M
$16.5M
Dividends payable
$31.0M
$28.5M
$25.7M
$23.1M
Income tax payable
$3.9M
$4.5M
$5.0M
$2.3M
Operating lease liabilities - current
$3.6M
$3.1M
$3.9M
$3.8M
Finance lease liabilities - current
$205.0K
$194.0K
$272.0K
$226.0K
Total current liabilities
$176.4M
$157.7M
$148.5M
$140.0M
Revolving loan
$164.0M
$190.0M
$309.6M
$440.6M
Deferred income taxes
$54.1M
$43.7M
$52.0M
$62.8M
Operating lease liabilities - non-current
$11.3M
$13.0M
$14.6M
$13.8M
Finance lease liabilities - non-current
$1.5M
$1.7M
$1.9M
$2.2M
Other long-term obligations
$21.4M
$19.3M
$16.6M
$26.8M
Total liabilities
$428.8M
$425.5M
$543.2M
$686.2M
Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding
0
0
0
0
Common stock, $.0667 par value. Authorized 120,000,000 shares; 32,058,121 shares issued and outstanding at December 31, 2025 and 32,527,244 shares issued and outstanding at December 31, 2024, respectively
2.1M
2.2M
2.2M
2.1M
Additional paid-in capital
$92.3M
$174.0M
$145.7M
$128.8M
Retained earnings
$1.1B
$997.5M
$897.5M
$814.5M
Accumulated other comprehensive income (loss)
$41.5M
($23.7M)
$8.7M
($7.2M)
Total stockholders’ equity
$1.3B
$1.1B
$1.1B
$938.3M
Total liabilities and stockholders’ equity
$1.7B
$1.6B
$1.6B
$1.6B
Balchem Corp balance sheet, quarters
Line item
Sep 30, 2026
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Cash and cash equivalents
$66.3M
$63.2M
$72.9M
$65.1M
Accounts receivable, net of allowance for credit losses of $1,262 and $862 at September 30, 2026 and December 31, 2025, respectively
$145.6M
$149.0M
$154.2M
$131.5M
Inventories, net
$177.0M
$161.6M
$146.7M
$132.4M
Prepaid expenses
$9.9M
$8.5M
$9.0M
$8.9M
Other current assets
$6.0M
$5.3M
$6.1M
$5.7M
Total current assets
$404.9M
$388.4M
$388.9M
$343.7M
Property, plant and equipment, net
$306.1M
$304.7M
$303.1M
$297.8M
Goodwill
$807.5M
$808.8M
$811.5M
$816.5M
Customer relationships and lists, net
$120.1M
$123.7M
$127.7M
$136.1M
Other intangible assets with finite lives, net
$27.3M
$27.9M
$28.8M
$31.3M
Right of use assets - operating leases
$16.3M
$12.7M
$13.7M
$15.9M
Right of use assets - finance lease
$1.4M
$1.4M
$1.5M
$1.6M
Other non-current assets
$20.0M
$19.3M
$18.7M
$18.0M
Total assets
$1.7B
$1.7B
$1.7B
$1.7B
Trade accounts payable
$72.0M
$70.5M
$70.7M
$47.0M
Accrued expenses
$59.2M
$51.8M
$51.8M
$48.6M
Accrued compensation and other benefits
$26.4M
$20.0M
$12.7M
$20.1M
Dividends payable
$164.0K
$166.0K
$169.0K
$113.0K
Income taxes payable
$2.4M
$0
$13.5M
$6.5M
Operating lease liabilities - current
$3.8M
$3.2M
$3.4M
$3.9M
Finance lease liabilities - current
$213.0K
$210.0K
$207.0K
$202.0K
Total current liabilities
$164.1M
$145.8M
$152.5M
$126.4M
Revolving loan
$124.0M
$152.0M
$169.0M
$154.0M
Deferred income taxes
$52.3M
$52.9M
$53.4M
$47.6M
Operating lease liabilities - non-current
$13.1M
$9.9M
$10.6M
$12.3M
Finance lease liabilities - non-current
$1.4M
$1.4M
$1.5M
$1.6M
Other long-term obligations
$21.9M
$22.6M
$21.6M
$21.3M
Total liabilities
$376.8M
$384.6M
$408.6M
$363.2M
Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding
0
0
0
0
Common stock, $0.0667 par value. Authorized 120,000,000 shares; 31,824,039 and 32,058,121 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively
2.1M
2.1M
2.1M
2.2M
Additional paid-in capital
$47.2M
$66.7M
$89.5M
$141.0M
Retained earnings
$1.3B
$1.2B
$1.2B
$1.1B
Accumulated other comprehensive income
$24.4M
$27.2M
$31.7M
$41.6M
Total stockholders' equity
$1.3B
$1.3B
$1.3B
$1.3B
Total liabilities and stockholders' equity
$1.7B
$1.7B
$1.7B
$1.7B
Cash flow statement
Balchem Corp cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net earnings
$154.8M
$128.5M
$108.5M
$105.4M
Depreciation and amortization
$45.7M
$48.0M
$54.9M
$51.8M
Stock compensation expense
$18.1M
$16.7M
$16.1M
$13.2M
Deferred income taxes
$6.3M
($6.8M)
($10.8M)
($8.4M)
(Recovery of) provision for credit losses
($97.0K)
$299.0K
$37.0K
$401.0K
Unrealized gain on foreign currency transactions and deferred compensation
($680.0K)
($100.0K)
($733.0K)
—
Asset impairment charge and (gain) loss on disposal of assets
($58.0K)
$1.7M
$7.0M
—
Change in fair value of contingent consideration liability
$0
($91.0K)
($11.3M)
—
Accounts receivable
($20.9M)
$5.6M
$7.0M
($3.6M)
Inventories
$3.6M
($22.8M)
$10.5M
($7.8M)
Prepaid expenses and other current assets
($1.3M)
$225.0K
($3.5M)
$1.9M
Accounts payable and accrued expenses
$11.3M
$9.1M
$3.6M
($15.5M)
Income taxes
($1.1M)
($583.0K)
$2.2M
$296.0K
Other
$865.0K
$2.4M
$305.0K
($423.0K)
Net cash provided by operating activities
$216.6M
$182.0M
$183.8M
$138.5M
Capital expenditures and intangible assets acquired
($43.5M)
($35.7M)
($37.9M)
($50.3M)
Cash paid for acquisitions, net of cash acquired
($323.0K)
($24.2M)
($1.3M)
($365.8M)
Proceeds from sale of assets
$274.0K
$359.0K
$1.9M
$206.0K
Proceeds from settlement of net investment hedge
$0
$0
$2.7M
—
Investment in affiliates
($353.0K)
($270.0K)
($290.0K)
—
Net cash used in investing activities
($43.9M)
($59.7M)
($34.8M)
($416.0M)
Proceeds from revolving loan
$88.0M
$26.0M
$18.0M
$435.0M
Principal payments on revolving debt
($114.0M)
($145.6M)
($149.0M)
($103.0M)
Principal payments on finance lease
($194.0K)
($216.0K)
($222.0K)
($177.0K)
Proceeds from stock options exercised
$9.3M
$17.2M
$5.2M
$3.2M
Dividends paid
($28.3M)
($25.6M)
($22.9M)
($20.7M)
Repurchases of common stock
($107.6M)
($5.7M)
($4.5M)
($35.4M)
Net cash used in financing activities
($152.8M)
($133.8M)
($153.3M)
$246.7M
Effect of exchange rate changes on cash
$5.2M
($3.4M)
$2.3M
($5.9M)
Increase (decrease) in cash and cash equivalents
$25.1M
($14.9M)
($2.1M)
($36.7M)
Cash and cash equivalents beginning of period
$49.5M
$64.4M
$66.6M
$103.2M
Cash and cash equivalents end of period
$74.6M
$49.5M
$64.4M
$66.6M
Balchem Corp cash flow statement, quarters
Line item
Sep 30, 2026 · YTD
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Net earnings
$131.6M
$84.9M
$40.3M
$115.6M
Depreciation and amortization
$37.1M
$24.7M
$12.5M
$34.0M
Stock compensation expense
$16.3M
$11.3M
$5.4M
$14.3M
Deferred income taxes
($860.0K)
($354.0K)
($187.0K)
($273.0K)
Provision for (recovery of) credit losses
$410.0K
$274.0K
$289.0K
($118.0K)
Unrealized loss (gain) on foreign currency transactions and deferred compensation
$944.0K
$688.0K
$717.0K
($1.2M)
Loss (gain) on disposal of assets and asset impairment
$2.5M
$492.0K
$151.0K
—
Accounts receivable
($3.0M)
($6.5M)
($11.4M)
($8.9M)
Inventories
($47.3M)
($31.4M)
($16.2M)
$2.6M
Prepaid expenses and other current assets
($194.0K)
$1.9M
$763.0K
$24.0K
Accounts payable and accrued expenses
$19.5M
$4.8M
($1.6M)
($9.0M)
Income taxes
($1.7M)
($4.8M)
$9.5M
$1.4M
Other
$1.2M
$744.0K
($112.0K)
$924.0K
Net cash provided by operating activities
$156.5M
$86.8M
$40.1M
$149.3M
Capital expenditures and intangible assets acquired